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oachim Schofer, MD,* Melanie Arendt, MD,* Thilo Tübler, MD,* Jörn Sandstede, MD,†
ichael Schlüter, PHD*
amburg, Germany
bjectives This study sought to assess the timing of cerebral ischemia after emboli-protected ca-
otid artery stenting (CAS).
ackground Predominantly clinically silent cerebral ischemia has been observed in up to 50% of
atients undergoing emboli-protected CAS. The timing and location of cerebral ischemia has not
een sufﬁciently elucidated.
ethods In 58 patients (69.6  8.3 years) who underwent 59 procedures, diffusion-weighted mag-
etic resonance imaging (DWMRI) was performed before the intervention and at 2 time points (t1
nd t2) after the intervention.
esults No patient showed recent cerebral injury before CAS. At t1  3.5  1.8 h, new ischemic
oci, all located in the ipsilateral hemisphere, were observed in 12 of 59 DWMRI studies (20.3%, 95%
onﬁdence interval: 11.0% to 32.8%). At t2  18.0  3.1 h, 7 more DWMRI scans showed recent
schemic foci, and 3 scans in patients with positive scans at t1 showed additional foci, for a total of
0 scans (17.0%, 95% conﬁdence interval: 8.4% to 29.0%) documenting late cerebral ischemia. In 4
f these (40%), ischemic foci were located contralaterally. Cerebral ischemia was not associated with
vert neurological sequelae out to 30 days in any patient.
onclusions The incidence of late cerebral ischemia occurring between 3.5 and 18 h after emboli-
rotected CAS was 17%. It may occur with equal likelihood in either hemisphere. Preventive mea-
ures to possibly reduce the incidence of cerebral embolization should focus not only on the target
esion, but also on the access vasculature. Patients should be monitored and DWMRI delayed for at
east 18 h after the intervention. (J Am Coll Cardiol Intv 2008;1:571–7) © 2008 by the American
ollege of Cardiology Foundation
rom the *Medical Care Center Prof. Mathey, Prof. Schofer and Hamburg University Cardiovascular Center, and †Röntgen-
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572mboli-protected carotid artery stenting (CAS) is being
ncreasingly used as a less invasive alternative to carotid
ndarterectomy for the treatment of patients with high-
rade symptomatic and asymptomatic carotid artery steno-
is. However, despite the introduction of embolic protection
evices, the cumulative 30-day stroke and death rate of this
rocedure is still in the range of 6% to 12% (1–4) depending
n the risk profile of the patients. Diffusion-weighted
agnetic resonance imaging (DWMRI) is a highly sensitive
ool for the detection of cerebral ischemia. Ischemic regions
an be identified as hyperintense areas within minutes of
nset, as has been shown experimentally and in vivo (5,6).
he DWMRI studies have been performed before and after
rotected carotid artery stent procedures, revealing new
ost-procedural ischemia of the brain in 20% to 50% of
atients. In the vast majority of patients, these lesions
emain clinically silent (7–12).
See page 578
In terms of patient care after the procedure, it is impor-
ant to know whether the occurrence of cerebral ischemia is
restricted to the duration of the
procedure itself or is an ongoing
process lasting for several hours.
Therefore, the purpose of the
present study was to assess the
time course of cerebral ischemia
after emboli-protected CAS by
way of sequential DWMRI.
ethods
atients. Between April 2006 and June 2007, 58 consecu-
ive patients without contraindications for DWMRI who
ad either a symptomatic carotid artery stenosis of at least
0% or an asymptomatic stenosis of at least 80% underwent
total of 59 elective emboli-protected CAS procedures at
ur institution. Eight procedures were performed for a
esion that had given rise to neurological symptoms within
he previous 6 months, and 51 procedures (86%) were
erformed for an asymptomatic lesion. Written informed
onsent was obtained from all patients. Pertinent patient
nd lesion characteristics are summarized in Table 1.
agnetic resonance angiography. Magnetic resonance an-
iography of the aortic arch, the supra-aortic arteries, and
he intracerebral arteries was performed before the proce-
ure to assess vessel anatomy and pathology as well as target
esion morphology.
AS procedure. The CAS procedure as performed at our
nstitution has been described in detail previously (8). In
hort, patients were either pre-medicated with clopidogrel
bbreviations
nd Acronyms
AS  carotid artery
tenting
I  confidence interval
WMRI  diffusion-weighted
agnetic resonance imaging75 mg/day) and aspirin (100 mg/day) for at least 3 days or tiven a loading dose of clopidogrel (600 mg) immediately
efore the intervention. In all patients, a bolus of 70 IU/kg
o 100 IU/kg heparin was administered at the start of the
rocedure. Glycoprotein IIb/IIIa antagonists were not used.
long sheath (Shuttle-SL, Cook Medical Inc., Blooming-
on, Indiana) was introduced into the common carotid
rtery by way of the femoral artery. Fluoroscopic visualiza-
ion of the target carotid artery, and in patients with
ilateral carotid disease on magnetic resonance angiography,
lso of the contralateral carotid artery, was then performed.
n the majority of interventions, a filter device (mostly [n 
4] the Emboshield BareWire Embolic Protection System,
bbott Vascular, Abbott Park, Illinois) was subsequently
laced distal to the target lesion. In 3 patients who had
20-mm lesions with a 90% stenosis, a distal occlusive
alloon system (GuardWire, Medtronic Inc., Minneapolis,
innesota) was used instead, and a proximal flow-blockage
ystem (Mo.Ma, Invatec s.r.l., Roncadelle, Italy) was used in
patient with a severely tortuous vessel distal to the target
esion. Once embolic protection was established, lesions
ere pre-dilated (only if the stenosis was severely calcified or
aused 90% lumen narrowing) and stenting was carried
ut. The Acculink Carotid Stent System (Abbott Vascular)
as predominantly (n  54) used. Post-dilation with a
lightly undersized balloon (nominal diameter 0.5 to 1.0
m less than the reference vessel diameter) was performed
n all stented lesions. Carotid and intracerebral angiography
oncluded the procedure. Patients were discharged on an
ral regimen of clopidogrel (75 mg/day for 4 weeks) and
spirin (100 mg/day indefinitely).
agnetic resonance imaging. The DWMRI scans of the
rain using a 1.5-T whole-body system (Magnetom Sonata,
iemens, Erlangen, Germany) were obtained within 24 h
efore CAS and at 2 time points after CAS: within 6 h (t1)
nd between 18 h and 24 h (t2). The DWMRI protocol
onsisted of a diffusion-weighted echo-planar imaging se-
uence (b 1,000 mm2/s, TR 2,900 ms, TE 84 ms) in axial
can direction, with diffusion gradients simultaneously ap-
lied on all 3 axes. All images were reviewed by 1 experi-
nced radiologist (J.Sa.). In all cases in which ischemic foci
ere seen for the first time during t2, a repeat review of the
1 scans was performed to verify absence of ischemic foci
uring t1.
Hyperintense foci on DWMRI were described by their
umber, location in the brain, and size. Location of foci was
efined as ipsilateral if they were found in the territory
ubtended by the culprit carotid artery, and otherwise as
onipsilateral. For size determination, hyperintense foci
ere marked manually, whereupon the area was calculated
utomatically by the system. Areas were then presented as
ean area per patient, maximum area (area of the largest
pot), and total area (sum of all identified foci).
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573xamination included a calculation of the National Insti-
utes of Health Stroke Scale and was repeated immediately
fter the intervention and before discharge.
tatistics. Continuous variables are presented by their mean
1 SD or, where appropriate, by their median and
nterquartile range. Nominal variables are presented as
ounts and percentages. Exact 95% confidence intervals
CIs) were calculated based on the binomial distribution.
roup differences between continuous variables were com-
ared using the Mann-Whitney U test. Comparisons be-
ween nominal variables were performed using the Fisher
xact text. These analyses used the StatView 4.5 software
ackage (Abacus Concepts, Inc., Berkeley, California). A
-tailed p value  0.05 was considered statistically
ignificant.
esults
ll procedures were successfully completed within 28  12
in. Embolic protection devices were used as intended in all
rocedures; they were in effect for a mean of 4.8 min. A de
Table 1. Baseline Patient, Lesion, and Procedure Characteristics
Patients (N  58)
Age, yrs 69.6 8.3
Age 75 yrs, n (%) 16 (27)
Men, n (%) 39 (67)
Diabetes mellitus, n (%) 17 (29)
Hypertension, n (%) 53 (91)
Hyperlipidemia, n (%) 42 (72)
Previous/current smoking, n (%) 32 (55)
Bilateral carotid disease, n (%) 16 (28)
Target lesion (N  59)
Left internal carotid artery, n (%) 27 (46)
Right internal carotid artery, n (%) 32 (54)
De novo, n (%) 57 (97)
Eccentric, n (%) 54 (92)
Ulcerated, n (%) 26 (44)
Calciﬁed, n (%) 33 (56)
Lesion-related neurological symptoms within previous
6 months, n (%)
8 (14)
Diameter stenosis, %* 80 10
Lesion length, mm 15 6
Procedures (N  59)
Procedure duration, min 28 12
Type of embolic protection device used
Distal ﬁlter, n (%) 55 (93)
Distal balloon, n (%) 3 (5)
Proximal balloon, n (%) 1 (2)
Dwell time of embolic protection device, min 4.8 1.5
Type of stent implanted
Open cell 57 (97)
Closed cell 1 (2)
*Visual estimate.ovo lesion was treated in the majority (97%) of cases; 3nterventions (2 with stenting, 1 with balloon angioplasty
nly) were performed for in-stent restenoses. No patient
xperienced neurological symptoms periprocedurally out to
0 days. Pertinent procedural details are given in Table 1.
WMRI ﬁndings. Before intervention, no patient showed
igns of recent cerebral ischemia on DWMRI. The first
ollow-up DWMRI study took place 3.5  1.8 h after the
ntervention (t1) and revealed new cerebral ischemic foci in
2 of 59 studies (20.3%, 95% CI: 11.0% to 32.8%). At the
ime (t2) of the second follow-up DWMRI study, at 18.0
.1 h, 7 more studies (11.9%, 95% CI: 4.9% to 22.9%)
evealed new cerebral ischemia. Moreover, 3 studies (5.1%,
5% CI: 1.1% to 14.2%) showed additional foci in patients
ho already had a positive DWMRI scan at t1. Thus, a total
f 10 studies (17.0%, 95% CI: 8.4% to 29.0%) revealed new
r additional foci at t2, and the overall incidence of new
erebral ischemia at a mean of 18 h after emboli-protected
AS was 32.2% (19 studies, 95% CI: 20.6% to 45.6%) (Fig. 1).
The incidence of new cerebral ischemia in selected
atient and lesion subgroups is given in Table 2. Except for
iabetic patients, in whom a tendency toward an increased
ncidence was observed (50% vs. 24% in nondiabetics, p 
.072), no other patient or lesion characteristic seemed to
mpact the incidence of new cerebral ischemia.
All ischemic foci detected at t1 were located in the
psilateral hemisphere. In contrast, of the late (new or
dditional) ischemic foci that were first seen at t2, these were
ocated exclusively ipsilaterally in only 6 of 10 DWMRI
tudies. Three studies detected ischemic foci solely in the
ontralateral hemisphere, and 1 study showed 1 ischemic
ocus each in both the ipsilateral and the contralateral
emisphere, for a total of 4 of 10 studies (40%, 95% CI:
2.2% to 73.8%) revealing contralateral cerebral ischemia at
2. Of the late contralateral foci, 3 (75%) occurred in
atients with bilateral carotid disease. The affected con-
19 (32%)
12 (20%) t1 (3.5±1.8 h): 
t2 (18.0±3.1 h): 7 (12%) 3 (5%)
Additional foci 
New cerebral ischemic foci 
59 CAS Procedures
Figure 1. Cerebral Ischemia on Sequential DWMRI
Flowchart showing new cerebral ischemic foci at time points t1 and t2 after
CAS, as well as additional foci at t2 in 3 patients who already had cerebral
ischemic foci at t1. CAS  carotid artery stenting; DWMRI  diffusion-
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574ralateral hemisphere was the left and right hemisphere in 2
ases each. In the latter, the left common carotid artery
riginated in close proximity to the origin of the brachio-
ephalic artery in 1 patient, whereas in the other, it
riginated directly from the brachiocephalic artery (Fig. 2).
ith respect to the occurrence of late foci, no patient or
esion characteristic was found to exert an influence (Table 2).
The number of ischemic foci in all 31 studies with
ositive DWMRI scans ranged from 1 to 5, with the area
overed by an ischemic focus ranging from 3 mm2 to 94
m2. Descriptive statistics of ischemic foci seen at t1 and t2
re given in Table 3. Multiple foci were significantly more
ften observed in patients 75 years than in patients 75
ears (5 of 16 [31%] vs. 3 of 43 [7%], respectively, p 
.0278) and tended to occur more frequently in patients
ith symptomatic lesions (3 of 8 [38%] vs. 5 of 51 [10%] in
atients with asymptomatic lesions, p  0.0678). The
ymptomatic lesion status was also the only variable to
mpact the size of ischemic foci: in patients with a symp-
omatic lesion, the mean area of the ischemic foci was
ignificantly larger than in patients with an asymptomatic
esion (48 mm2 vs. 31 mm2, respectively, p  0.0205).
iscussion
s a diagnostic tool capable of visualizing ischemia of the
Table 2. Cerebral Ischemia on DWMRI in Selected Patient and Lesion Subg
No. of CAS Procedures New Cerebral
Total 59 19 (32
Patient subgroups
Men 40 13 (33
Women 19 6 (32
Age 75 yrs 43 12 (28
Age 75 yrs 16 7 (44
Nondiabetic 41 10 (24
Diabetic 18 9 (50
Normal lipids 16 6 (38
Hyperlipidemia 43 13 (30
Nonsmoker 26 11 (42
Smoker 33 8 (24
Unilateral disease 43 13 (30
Bilateral disease 16 6 (38
Lesion subgroups
Noncalciﬁed 26 10 (39
Calciﬁed 33 9 (27
Nonulcerated 33 10 (30
Ulcerated 26 9 (35
Asymptomatic 51 15 (29
Symptomatic 8 4 (50
Values are n (%).
CAS carotid artery stenting;DWMRIdiffusion-weightedmagnetic resonance imaging; late
at t1 and t2.rain within minutes of onset, DWMRI has been used to ossess procedure-related cerebral ischemia after both carotid
ndarterectomy (9,13,14) and carotid angioplasty and stent-
ng with and without embolic protection (7–12). Follow-up
WMRI has usually been performed once within 12 to
8 h of the intervention and has yielded incidences of new
ocal cerebral ischemia between 4% (13) and 17% (14) for
arotid endarterectomy and between 23% (8) and 49% (12)
or emboli-protected CAS. In the present study, post-
rocedural DWMRI was performed twice: at a mean of
.5 h and again at a mean of 18 h after the intervention,
ielding overall incidences of new cerebral ischemia of
0% and 32%, respectively. In the first post-procedural
WMRI, ischemic foci were exclusively found in the
erritory subtended by the targeted carotid artery, whereas in
he second post-procedural DWMRI, 40% of ischemic
esions were located in the contralateral hemisphere.
Our results indicate that the embolic process after
mboli-protected CAS is not restricted to the intervention
tself but may still occur within an average time frame of 3.5
o 18 h after the intervention. Thus, this study confirms the
henomenon of late embolization first reported in a recent
nvestigation (15).
echanisms of new and late cerebral ischemia. The finding
f exclusively ipsilateral ischemic lesions at the first
ollow-up DWMRI study suggests that these early lesions
mia p Value Late Cerebral Ischemia p Value
10 (17)
0.999 7 (18) 0.999
3 (16)
0.348 6 (14) 0.436
4 (25)
0.072 5 (12) 0.256
5 (28)
0.755 2 (13) 0.713
8 (19)
0.169 6 (23) 0.311
4 (13)
0.755 7 (16) 0.999
3 (19)
0.410 6 (23) 0.311
4 (13)
0.784 6 (18) 0.999
4 (15)
0.417 9 (18) 0.999
1 (13)
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575ntervention or shortly thereafter. The most likely mecha-
ism is the liberation of atherosclerotic particulate matter
uring one (or more) of several stages of the intervention:
heath placement in the common carotid artery, maneuver-
ng through the carotid lesion, and placement of the distal
mbolic protection device, passage of particles through the
lter pores or past a malapposed filter during stenting,
ncomplete aspiration of debris after stenting in the presence
f a balloon occlusive protection system, withdrawal of the
mbolic protection device after stenting, and protrusion
ith subsequent release of atherosclerotic matter through
he stent meshes.
Both ipsilateral and contralateral ischemic foci were
bserved at the second follow-up DWMRI study. Although
t is conceivable that late ipsilateral foci have originated
rom the stented site, the approximate incidence ratio of
0:50 between late ipsilateral and late contralateral foci
Figure 2. Magnetic Resonance Angiography
Left common carotid artery (CCA) originating from brachiocephalic artery
(arrow). A  anterior; L  left.oints to a different mechanism for late cerebral ischemia.hrombus apposition to wall segments close to or at the
rigin of the brachiocephalic artery injured during the
dvancement of endoluminal equipment into the left com-
on carotid artery may have given rise to thromboembolic
atter to be carried downstream with equal likelihood into
ither hemisphere, particularly in cases in which the left
ommon carotid artery originates in close proximity to the
rachiocephalic artery. Although it is noteworthy that 3 of
he 4 late contralateral foci were observed in patients with
ilateral carotid disease, this increased incidence seems to be
chance finding because the overall incidences of new
erebral foci was not different between patients with unilat-
ral disease and patients with bilateral disease (Table 2),
hus making an influence of the selective introduction of a
iagnostic catheter for fluoroscopic visualization of the
espective carotid artery unlikely.
mpact of patient/lesion characteristics on late cerebral isch-
mia. We were not able to identify any patient or lesion
haracteristic predisposing to the occurrence of late cerebral
schemia, which may thus be a phenomenon inherent, with
likelihood ranging from 5% to 23%, to any emboli-
rotected CAS procedure and to any patient undergoing the
ntervention. Elderly patients and patients with a previously
ymptomatic carotid lesion had (or tended to have) more
ften multiple ischemic lesions covering larger brain areas in
he latter patients, and diabetic patients tended toward an
ncreased overall incidence of post-CAS cerebral ischemia.
hese findings are probably related to advanced atheroscle-
osis in elderly, symptomatic, and diabetic patients, which,
owever, did not impact the incidence of late brain injury.
erebral ischemia and overt neurological sequelae. Within
0 days of the carotid intervention, neither we nor Rapp et
l. (15) observed neurological symptoms associated with
erebral ischemia on DWMRI. To date, all studies of
WMRI after emboli-protected CAS have consistently
eported a paucity of overt neurological complications in the
resence of focal ischemic brain injury (7–12). Apparently,
he lesion location in the brain (eloquent vs. noneloquent
rain regions [16]) as well as the embolic load determine
hether cerebral ischemia causes overt neurological deficits
Table 3. Analysis of Ischemic Foci on DWMRI
Time of Post-Procedural DWMRI
t1 t2
Time after CAS, h 3.5 1.8 18.0 3.1
Number of studies exhibiting ischemic foci 12 19
Number of ischemic foci* 1 (0–1) 1 (1–3)
Mean area,* mm2 29 (20–48) 37 (26–46)
Maximum area,* mm2 29 (20–59) 38 (26–58)
Total area,* mm2 29 (20–66) 42 (26–152)










































































J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 1 , N O . 5 , 2 0 0 8
O C T O B E R 2 0 0 8 : 5 7 1 – 7
Schofer et al.
Late Cerebral Embolism After Carotid Stenting
576r not. In a previous study, we found that the 1 patient of 10
ith post-CAS brain ischemia who sustained a major stroke
ad both a markedly higher number of ischemic foci (12, as
pposed to a median of 1, range 1 to 3, in the 9 patients
ithout neurological symptoms) and the largest area cov-
red by an ischemic focus (85 mm2, as opposed to 43 mm2,
he largest ischemic area found in a patient without neuro-
ogical symptoms) (8). These findings were recently sup-
orted by Kastrup et al. (12), who observed that patients
ho experienced a minor or major stroke after CAS, as
ompared with patients without neurological deficits, had a
ignificantly higher number of new DWMRI lesions (me-
ian 7.5 vs. median 1) and that patients with a major stroke
ad multiple ischemic lesions larger than 20 mm in diam-
ter, whereas patients with a minor stroke had multiple
schemic lesions 10 mm in diameter.
Despite the lack of overt neurological sequelae of
erebral ischemia observed in this study, our findings
eem to be supported by the Carotid RX Acculink/
ccunet Post-Approval Trial to Uncover Unanticipated
r Rare Events (CAPTURE) study of 3,500 patients, in
hich 38% of all strokes occurred later than 24 h after the
ntervention (17).
Little is known about the extent by which focal cerebral
schemia affects cognitive function. In a recent study, a
eterioration of cognitive function after emboli-protected
AS was observed at discharge in 18 of 22 patients with
erebral ischemia on post-CAS DWMRI (18). A decline in
ognitive function has also been found in elderly patients
ith silent brain infarcts (19).
linical implications. Our findings indicate that the use of
mbolic protection devices (distal filters in particular) during
AS does not completely prevent particulate matter from
ntering the ipsilateral cerebral vascular territory. Moreover,
he unprotected nonipsilateral cerebral vasculature may be
nvaded post-CAS by emboli presumably originating from
rauma to the aortic arch and/or the proximal part of the
rachiocephalic artery. To possibly reduce the incidence of
erebral embolization, preventive measures therefore need
ot only focus on the target lesion, but also on the access
asculature. Because the occurrence of both ipsilateral and
onipsilateral cerebral ischemia is not restricted to the actual
ntervention but continues for several hours, it seems advis-
ble to monitor the patients for at least 18 to 24 h after
ntervention and delay follow-up DWMRI until discharge,
o possibly capture the full extent of procedure-related
erebral ischemia. It is not known whether embolization
ccurs even later than 24 h after the intervention.
Further study is needed to: 1) clarify whether stronger or
rolonged heparinization reduces the incidence of late
erebral ischemia; and 2) elucidate the clinical impact of
ilent cerebral ischemia on neuropsychological function.
tudy limitations. The number of patients in this study is
airly low, giving rise to wide confidence intervals of
1roportions and precluding logistic regression analyses to
etermine predictive factors for new and late cerebral
schemia.
onclusions
his study showed that emboli-protected CAS may give
ise to clinically silent late embolization into the cerebral
asculature in 8% to 29% of patients, with a time lag
veraging 3.5 to 18 h after the intervention. Late emboli-
ation occurred in both the ipsilateral and contralateral
emisphere, whereas early embolization was only observed
n the ipsilateral hemisphere. Preventive measures to possi-
ly reduce the incidence of cerebral embolization should
ocus not only on the target lesion, but also on the access
asculature. To capture the full extent of CAS-related
erebral injury, patients should be monitored and DWMRI
elayed for at least 18 h after the intervention.
eprint requests and correspondence: Dr. Michael Schlüter,
edical Care Center Prof. Mathey, Prof. Schofer, Wörde-
anns Weg 25-27, D-22527 Hamburg, Germany. E-mail:
chlueter@herz-hh.de.
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